Molecular Approaches to Drug Design: From Target Identification to Delivery
A special issue of Molecules (ISSN 1420-3049).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 14
Special Issue Editor
Interests: anticancer drugs; medicinal chemistry; drug design; drug-resistant pathogens; and drug targets
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Modern drug (small molecule) design and development integrate medicinal chemistry, structural biology, computational modeling, toxicology, pharmacology, and drug formulation, including drug delivery. Each discipline is supported by basic and fundamental organic and inorganic chemistry, theoretical sciences, biochemistry, biology, and medicine. In addition to the development of small drug molecules via well-structured plans, protein-based therapeutics (e.g., monoclonal antibody drugs) have been successfully used in clinics and recognized for their potential. Increasing PCR-based techniques and whole-genome sequencing advance personalized (precision) medicine, potentially optimizing therapeutic outcomes. More selective small-molecule drugs, antibody drugs, and targeted therapies will change the landscape of healthcare in the next decade. The aim of this “Special Issue“ is to highlight the advancements in drug design and discovery. This Special Issue may include original research articles and reviews on drug targets, medicinal chemistry, chemical entities, assays, antibodies, computational chemistry, pharmacokinetic and dynamic aspects, and new strategies to use approved drugs.
Prof. Dr. Michio Kurosu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug design
- target identification
- drug delivery
- protein-based therapeutics
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
